Clinical depression ECT

Revision as of 16:55, 20 May 2021 by Mitra Chitsazan (talk | contribs) (→‎ECT)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Clinical Depression Microchapters

Home

Patient Information

Major Depressive Disorder (Patient Information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Clinical Depression from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Substance/Medication-induced Depressive Disorder

Depressive Disorder due to a Medical Condition

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

ECT

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-up

Follow-Up

Case Studies

Case #1

Clinical depression ECT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clinical depression ECT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clinical depression ECT

CDC on Clinical depression ECT

Clinical depression ECT in the news

Blogs on Clinical depression ECT

Directions to Hospitals Treating Clinical depression

Risk calculators and risk factors for Clinical depression ECT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

ECT

  • Electroconvulsive therapy (ECT), also known as electroshock or electroshock treatment, uses short bursts of a controlled current of electricity (typically fixed at 0.9 ampere) into the brain to induce a brief, artificial seizure while the patient is under general anesthesia.
  • In contrast to direct electroshock of years ago, most countries now allow ECT to be administered only under anesthesia.
  • In a typical regimen of treatment, a patient receives three treatments per week over three or four weeks. Repeat sessions may be needed.
  • Short-term memory loss, disorientation, and headache are common side effects. Detailed neuropsychological testing in clinical studies has not been able to prove permanent effects on memory.
  • ECT offers the benefit of a very fast response; however, this response has been shown not to last unless maintenance electroshock or maintenance medication is used. Whereas antidepressants usually take around a month to take effect, the results of ECT have been shown to be much faster. For this reason, it is the treatment of choice in emergencies (e.g., in catatonic depression in which the patient has ceased oral intake of fluid or nutrients).
  • ECT is most helpful in treating refractory major depressive disorder and major depressive episodes with psychotic features.

References

Template:WikiDoc Sources